RxDoctor Payments Data

Morgan Reinard, PA

Physician Assistant · du Bois, PANPI 1669148219

Payments from drug & device makers

$1,299in general payments, 2019–2025

Across 74 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$316
  • Exact Sciences$199
  • Amgen$142
  • Lilly USA, LLC$104
  • Abbott$100
  • Philips North America LLC$99
  • plus $339 from 10 others

What the payments were for

  • Food & beverage$1,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,299 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$37,730
Medicare patients
194
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$106,164
EliquisApixaban105$71,011
TrulicityDulaglutide73$66,735
JardianceEmpagliflozin62$57,607
XareltoRivaroxaban67$50,294
FarxigaDapagliflozin Propanediol44$35,121
JanuviaSitagliptin Phosphate19$22,947
MounjaroTirzepatide21$20,713
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$17,271
Breo ElliptaFluticasone/Vilanterol32$13,943
MyrbetriqMirabegron20$12,058
Repatha SureclickEvolocumab15$7,232
Levothyroxine Sodium636$5,762
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$5,587
Combivent RespimatIpratropium/Albuterol Sulfate11$5,294

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$316$106,164110 claims
Lilly USA, LLCTrulicity, Mounjaro$104$87,44894 claims
Boehringer IngelheimJardiance, Combivent Respimat$15$62,90173 claims
GSKTrelegy Ellipta, Breo Ellipta$33$31,21454 claims
MerckJanuvia$43$22,94719 claims
Astellas Pharma US IncMyrbetriq$15$12,05820 claims
AbbVieSynthroid$77$3,38779 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in du Bois

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →